Bibliographic record
Lixisenatide in patients with type 2 diabetes and acute coronary syndrome
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray…. New England Journal of Medicine 2015
§1Bibliographic record
§1.1Record
- Authors
- Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC
- Title
- Lixisenatide in patients with type 2 diabetes and acute coronary syndrome
- Source
- New England Journal of Medicine
- Year
- 2015
- Volume, issue, pages
- 373(23):2247–2257
- Digital object identifier
- 10.1056/NEJMoa1509225
- PubMed identifier
- 26630143
- Record type
- Journal article
- Institute identifier
- CEI-BR-084
§1.2Institute documents citing this record
Table 1. Documents in the Institute set that cite this record.
| Document | Series |
|---|---|
| Monograph: Lixisenatide | Compound monograph |
| Trial abstract: ELIXA | Trial abstract |
| Synthesis: Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists | Evidence synthesis |
| Synthesis: Lixisenatide in type 2 diabetes mellitus: effect on the anchor outcome | Evidence synthesis |
| Synthesis: Lixisenatide in type 2 diabetes mellitus: tolerability and… | Evidence synthesis |
| Synthesis: Lixisenatide in type 2 diabetes mellitus: durability of effect | Evidence synthesis |
| 6 citing documents. | |
§1.3Subject tags
lixisenatide cardiovascular ELIXA
Compound Evidence Institute · CEI-BR-084 · https://compoundevidence.com/bibliography/pfeffer2015/ · retrieved 30 July 2026